.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

EMADINE Drug Profile

« Back to Dashboard
Emadine is a drug marketed by Alcon and is included in one NDA. It is available from one supplier.

The generic ingredient in EMADINE is emedastine difumarate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the emedastine difumarate profile page.

Summary for Tradename: EMADINE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Pharmacology for Tradename: EMADINE

Clinical Trials for: EMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 1997RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: EMADINE

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 19974,430,343<disabled>
Alcon
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 19975,441,958<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc